Current Report Filing (8-k)
January 17 2023 - 5:06AM
Edgar (US Regulatory)
0001723648
false
0001723648
2023-01-13
2023-01-13
0001723648
LVOX:ClassaCommonStockParValue0.0001PerShareMember
2023-01-13
2023-01-13
0001723648
LVOX:RedeemableWarrantsEachWholeWarrantExercisableToPurchaseOneShareOfClassaCommonStockAtExercisePriceOf11.50Member
2023-01-13
2023-01-13
0001723648
LVOX:UnitsEachConsistingOfOneShareOfClassaCommonStockAndOnehalfOfOneRedeemableWarrantMember
2023-01-13
2023-01-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
January 13, 2023
LIVEVOX HOLDINGS, INC.
(Exact name of registrant as specified in its
charter)
Delaware
(State or other jurisdiction of
incorporation
or organization) |
001-38825
(Commission File
Number) |
82-3447941
(I.R.S. Employer Identification
Number) |
655 Montgomery Street, Suite 1000
San Francisco, CA 94111
(Address of principal executive offices and zip code)
(415) 671-6000
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading
Symbol |
Name of each exchange
on which registered |
Class A common stock, par value $0.0001 per share |
LVOX |
The NASDAQ Stock Market LLC |
Redeemable Warrants, each whole Warrant exercisable to purchase one share of Class A common stock at an exercise price of $11.50 |
LVOXW |
The NASDAQ Stock Market LLC |
Units, each consisting of one share of Class A common stock and one-half of one redeemable Warrant |
LVOXU |
The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item
2.05 - Costs Associated with Exit or Disposal Activities
On January 13, 2023, LiveVox Holdings, Inc. (the
“Company”) authorized a new cost reduction plan (the “CRP”). Management, with the oversight and guidance of the
Company’s board of directors, determined to implement the CRP following a review of the Company’s business, operating expenses
and the macroeconomic environment. The CRP is intended to reduce the Company’s cost structure and improve its operational efficiency.
The CRP will include a reduction of
approximately 96 employees, comprising approximately 16% of the Company’s global workforce. In connection with the CRP, the
Company estimates that it will record an aggregate restructuring charge in the first quarter related to one-time termination
benefits in the range of $3.0 million to $3.5 million, the substantial majority of which will result in cash expenditures.
Cash expenditures in connection with the CRP consist
of payments for salary, benefits, and unused paid time off for the affected employees through their termination date. The CRP will also
consist of a severance package that includes a cash severance payment, payments to cover the employer premiums and administration fees
for continuation of healthcare coverage for a limited period, and outplacement services.
Each affected employee’s eligibility
for the severance benefits is contingent upon such employee’s execution (and non - revocation) of a separation agreement,
which includes a general release of claims against the Company. The Company expects payments relating to the CRP to be completed by
the end of the first quarter of 2023.
The estimates of the charges and expenditures
that the Company expects to incur in connection with the CRP, and the timing thereof, are subject to a number of assumptions, including
local law requirements in various jurisdictions, and actual amounts may differ materially from estimates. In addition, the Company may
incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection
with the implementation of the CRP. A letter to the Company’s employees from John DiLullo, the Company’s Chief Executive Officer,
regarding the employee restructuring under the CRP is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated
by reference.
Item 5.02 - Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On January 13, 2023, the employment of Erik
Fowler, our former Chief Revenue Officer, was terminated, to be effective January 20, 2023, in connection with the CRP. In
connection with his departure, Mr. Fowler is expected to receive payment of a lump sum equal to 36 weeks of his base salary,
two months of continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, and up to three months of outplacement services to be paid by the Company, subject to his execution of a separation
and release agreement and compliance with post-termination restrictive covenants.
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking
statements, including, but not limited to, statements related to the expected benefits of and timing of completion of the CRP, and the
expected costs and charges of the CRP. Words such as “expects,” “anticipates,” “aims,” “projects,”
“intends,” “plans,” “believes,” “estimates,” “seeks,” “assumes,”
“may,” “should,” “could,” “would,” “foresees,” “forecasts,” “predicts,”
“targets,” “commitments,” variations of such words and similar expressions are intended to identify such forward-looking
statements. These forward-looking statements are based upon the Company’s current plans, assumptions, beliefs, and expectations.
Forward-looking statements are subject to the occurrence of many events outside of the Company’s control. Actual results and the
timing of events may differ materially from those contemplated by such forward-looking statements due to numerous factors that involve
substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, the risk that the restructuring
costs and charges may be greater than anticipated; the risk that the Company’s restructuring efforts may adversely affect the Company’s
internal programs and the Company’s ability to recruit and retain skilled and motivated personnel, and may be distracting to employees
and management; the risk that the Company’s restructuring efforts may negatively impact the Company’s business operations
and reputation with or ability to serve customers; the risk that the Company’s restructuring efforts may not generate their intended
benefits to the extent or as quickly as anticipated; and other risks and uncertainties included in the reports on Forms 10-K, 10-Q and
8-K and in other filings the Company makes with the Securities and Exchange Commission from time to time, available at www.sec.gov. Forward-looking
statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance
on forward-looking statements. All forward-looking statements contained herein speak only as of the date hereof. The Company assumes no
obligation and does not intend to update these forward-looking statements, except as required by law.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibit.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
LIVEVOX HOLDINGS, INC. |
|
|
|
Date: January 17, 2023 |
By: |
/s/ Gregg Clevenger |
|
Name: |
Gregg Clevenger |
|
Title: |
Executive Vice President and Chief Financial Officer |
LiveVox (NASDAQ:LVOX)
Historical Stock Chart
From Dec 2024 to Jan 2025
LiveVox (NASDAQ:LVOX)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about LiveVox Holding Inc (NASDAQ): 0 recent articles
More Livevox Holdings, Inc. News Articles